LifeMine Raises $263M to Advance LIFE-001 Transplant Therapy
WATERTOWN, Mass., August 6, 2026 LifeMine Therapeutics has secured $263 million in financing to accelerate the clinical development of...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
WATERTOWN, Mass., August 6, 2026 LifeMine Therapeutics has secured $263 million in financing to accelerate the clinical development of...
SILVER SPRING, Maryland & RESEARCH TRIANGLE PARK, North Carolina, July 2, 2026 United Therapeutics Corporation has announced the acquisition...
NEW YORK, N.Y. | June 2026 NYU Langone Health has successfully performed the world’s first HIV-positive-to-HIV-positive lung transplant, marking...
Oxford, England, and Madison, New Jersey, October 30, 2025 — Terumo Corporation, a global leader in medical technology, has...
